1. Home
  2. ARCT vs CRML Comparison

ARCT vs CRML Comparison

Compare ARCT & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • CRML
  • Stock Information
  • Founded
  • ARCT 2013
  • CRML N/A
  • Country
  • ARCT United States
  • CRML United States
  • Employees
  • ARCT N/A
  • CRML N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • CRML
  • Sector
  • ARCT Health Care
  • CRML
  • Exchange
  • ARCT Nasdaq
  • CRML NYSE
  • Market Cap
  • ARCT 298.3M
  • CRML 298.8M
  • IPO Year
  • ARCT N/A
  • CRML N/A
  • Fundamental
  • Price
  • ARCT $13.19
  • CRML $3.58
  • Analyst Decision
  • ARCT Strong Buy
  • CRML
  • Analyst Count
  • ARCT 8
  • CRML 0
  • Target Price
  • ARCT $52.33
  • CRML N/A
  • AVG Volume (30 Days)
  • ARCT 497.0K
  • CRML 7.0M
  • Earning Date
  • ARCT 08-04-2025
  • CRML 02-01-2025
  • Dividend Yield
  • ARCT N/A
  • CRML N/A
  • EPS Growth
  • ARCT N/A
  • CRML N/A
  • EPS
  • ARCT N/A
  • CRML N/A
  • Revenue
  • ARCT $143,680,000.00
  • CRML $476,979.00
  • Revenue This Year
  • ARCT N/A
  • CRML N/A
  • Revenue Next Year
  • ARCT $34.79
  • CRML N/A
  • P/E Ratio
  • ARCT N/A
  • CRML N/A
  • Revenue Growth
  • ARCT 15.38
  • CRML 326.80
  • 52 Week Low
  • ARCT $8.04
  • CRML $1.23
  • 52 Week High
  • ARCT $25.88
  • CRML $11.60
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 66.19
  • CRML 68.00
  • Support Level
  • ARCT $12.03
  • CRML $2.10
  • Resistance Level
  • ARCT $14.75
  • CRML $3.85
  • Average True Range (ATR)
  • ARCT 0.79
  • CRML 0.54
  • MACD
  • ARCT 0.20
  • CRML 0.16
  • Stochastic Oscillator
  • ARCT 89.96
  • CRML 89.02

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About CRML CRITICAL METALS CORPORATION

Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.

Share on Social Networks: